Literature DB >> 18549442

Immunity and Toxoplasma retinochoroiditis.

G R Wallace1, M R Stanford.   

Abstract

Toxoplasma infection accounts for up to 50% of all cases of posterior uveitis worldwide. In this review the control of Toxoplasma infection generally, and specific in the eye, by the immune system is discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18549442      PMCID： PMC2527354          DOI： 10.1111/j.1365-2249.2008.03692.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  67 in total

1.  Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G Yap; M Pesin; A Sher
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Unexpected autopsy findings arising from postmortem ocular examination.

Authors:  K J Butnor; A D Proia
Journal:  Arch Pathol Lab Med       Date:  2001-09       Impact factor: 5.534

3.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis.

Authors:  M E Grigg; J Ganatra; J C Boothroyd; T P Margolis
Journal:  J Infect Dis       Date:  2001-07-24       Impact factor: 5.226

4.  Postmortem histological survey of the ocular lesions in a British population of AIDS patients.

Authors:  I Pecorella; A Ciardi; A Garner; A C McCartney; S Lucas
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 5.  Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease?

Authors:  John C Boothroyd; Michael E Grigg
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

6.  IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.

Authors:  C A Hunter; R Chizzonite; J S Remington
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

7.  Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis.

Authors:  S Hayashi; C C Chan; R Gazzinelli; F G Roberge
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

8.  Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite.

Authors:  J M Dobrowolski; L D Sibley
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

9.  Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

10.  Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection.

Authors:  Julio Aliberti; Charles Serhan; Alan Sher
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307
View more
  12 in total

1.  Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection.

Authors:  Barbara A Fox; Alejandra Falla; Leah M Rommereim; Tadakimi Tomita; Jason P Gigley; Corinne Mercier; Marie-France Cesbron-Delauw; Louis M Weiss; David J Bzik
Journal:  Eukaryot Cell       Date:  2011-04-29

2.  Identification of a sporozoite-specific antigen from Toxoplasma gondii.

Authors:  Dolores Hill; Cathleen Coss; J P Dubey; Kristen Wroblewski; Mari Sautter; Tiffany Hosten; Claudia Muñoz-Zanzi; Ernest Mui; Shawn Withers; Kenneth Boyer; Gretchen Hermes; Jessica Coyne; Frank Jagdis; Andrew Burnett; Patrick McLeod; Holmes Morton; Donna Robinson; Rima McLeod
Journal:  J Parasitol       Date:  2011-03-03       Impact factor: 1.276

3.  Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell's palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy.

Authors:  Maria Riga; G Kefalidis; A Chatzimoschou; G Tripsianis; S Kartali; H Gouveris; M Katotomichelakis; V Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-09       Impact factor: 2.503

Review 4.  Mechanisms of Toxoplasma gondii persistence and latency.

Authors:  William J Sullivan; Victoria Jeffers
Journal:  FEMS Microbiol Rev       Date:  2011-10-04       Impact factor: 16.408

5.  LFA-1/ ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model.

Authors:  Nannan Gao; Chong Wang; Yiran Yu; Linding Xie; Yien Xing; Yuan Zhang; Yanling Wang; Jianjun Wu; Yihong Cai
Journal:  PLoS Negl Trop Dis       Date:  2022-10-07

Review 6.  A latent ability to persist: differentiation in Toxoplasma gondii.

Authors:  Victoria Jeffers; Zoi Tampaki; Kami Kim; William J Sullivan
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

7.  Toxoplasma gondii oral infection induces intestinal inflammation and retinochoroiditis in mice genetically selected for immune oral tolerance resistance.

Authors:  Raul Ramos Furtado Dias; Eulógio Carlos Queiroz de Carvalho; Carla Cristina da Silva Leite; Roberto Carlos Tedesco; Katia da Silva Calabrese; Antonio Carlos Silva; Renato Augusto DaMatta; Maria de Fatima Sarro-Silva
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

8.  Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.

Authors:  Cristina S Meira; Vera L Pereira-Chioccola; José E Vidal; Cinara C Brandão de Mattos; Gabriela Motoie; Thais A Costa-Silva; Ricardo Gava; Fábio B Frederico; Luiz C de Mattos
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

9.  GRA24-Based DNA Vaccine Prolongs Survival in Mice Challenged With a Virulent Toxoplasma gondii Strain.

Authors:  Bin Zheng; Di Lou; Jianzu Ding; Xunhui Zhuo; Haojie Ding; Qingming Kong; Shaohong Lu
Journal:  Front Immunol       Date:  2019-03-06       Impact factor: 7.561

10.  Comparative studies of Toxoplasma gondii transcriptomes: insights into stage conversion based on gene expression profiling and alternative splicing.

Authors:  Long-Fei Chen; Xiao-Long Han; Fen-Xiang Li; Yun-Ying Yao; Jin-Ping Fang; Xiao-Ju Liu; Xiao-Cong Li; Kun Wu; Min Liu; Xiao-Guang Chen
Journal:  Parasit Vectors       Date:  2018-07-11       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.